GRAIL to Present at the BofA Securities 2026 Health Care Conference
GRAIL (Nasdaq: GRAL) will present at the BofA Securities 2026 Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 8:40 a.m. PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) will present at the BofA Securities 2026 Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 8:40 a.m. PT. Live and replay webcasts will be available via the investor relations site and archived for at least 30 days.
Details
News Market Reaction – GRAL
On May 1, the first trading day after this news, GRAL closed 0.77% below the previous close.
Data tracked by StockTitan Argus for the May 1 session.
Key Figures
- Conference date
- May 12, 2026
- BofA Securities 2026 Health Care Conference presentation date
- Presentation time
- 8:40 a.m. PT
- Scheduled time for management presentation
- Webcast archive period
- 30 days
- Replay availability after conference presentation
- Current price
- $49.79
- Pre-news close used in context data
- 24h price change
- -4.81%
- Move prior to conference announcement
- 52-week high
- $118.84
- Pre-news 52-week trading range high
- 52-week low
- $29.95
- Pre-news 52-week trading range low
- 200-day MA
- $66.61
- Longer-term trend reference level
Historical Context
-
Announced timing of Q1 2026 results release and webcast details.
-
Planned late-breaking NHS-Galleri and PATHFINDER 2 results at ASCO 2026.
-
Integration of Galleri test ordering/results into Epic EHR for ~450 systems.
-
Partnership with Superpower to offer Galleri through a preventative platform.
-
CEO retirement and appointment of Joshua Ofman as successor effective June 1.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-bofa-securities-2026-health-care-conference-302759240.html
SOURCE GRAIL, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.